-+ 0.00%
-+ 0.00%
-+ 0.00%

Harvard Bioscience Sees Q3 Sales $21.000M-$22.600M vs $21.850M Est

Benzinga·08/11/2026 11:03:42
语音播报
Harvard Bioscience (NASDAQ:HBIO) sees Q3 sales of $21.000 million-$22.600 million vs $21.850 million analyst estimate.